RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 39 filers reported holding RAIN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $875,059 | -28.3% | 1,015,385 | -0.1% | 0.00% | – |
| Q2 2023 | $1,219,836 | +84.9% | 1,016,530 | +1246.5% | 0.00% | – |
| Q1 2023 | $659,810 | +67.0% | 75,493 | +52.8% | 0.00% | – |
| Q4 2022 | $395,152 | -41.3% | 49,394 | -64.2% | 0.00% | – |
| Q3 2022 | $673,000 | -14.8% | 137,943 | -2.9% | 0.00% | – |
| Q2 2022 | $790,000 | -80.6% | 141,995 | -82.3% | 0.00% | – |
| Q1 2022 | $4,072,000 | -57.3% | 803,211 | +8.4% | 0.00% | – |
| Q4 2021 | $9,543,000 | +71.1% | 740,871 | +98.8% | 0.00% | – |
| Q3 2021 | $5,576,000 | +0.3% | 372,747 | +4.2% | 0.00% | – |
| Q2 2021 | $5,557,000 | – | 357,588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,571,379 | $7,967,000 | 2.01% |
| Cormorant Asset Management, LP | 2,326,660 | $11,796,000 | 0.91% |
| BVF INC/IL | 3,526,729 | $17,881,000 | 0.72% |
| Boxer Capital, LLC | 1,175,000 | $5,957,000 | 0.31% |
| Perceptive Advisors | 2,483,619 | $12,592,000 | 0.25% |
| Logos Global Management LP | 134,194 | $680,000 | 0.09% |
| Lumina Fund Management LLC | 6,000 | $30,000 | 0.01% |
| Woodline Partners LP | 119,700 | $607,000 | 0.01% |
| Trexquant Investment LP | 28,373 | $144,000 | 0.01% |
| Alyeska Investment Group, L.P. | 125,000 | $634,000 | 0.01% |